Michael Berger
Impact in
- Oncology top 10%
- Cancer Cells and Metastasis
- HER2/EGFR in Cancer Research
- Cancer Treatment and Pharmacology
- Cancer-related Molecular Pathways
-
- Cancer Genomics and Diagnostics
Papers in
- Oncology 9
- HER2/EGFR in Cancer Research 4
- Cancer Cells and Metastasis 3
- Lung Cancer Research Studies 1
-
- Advanced Breast Cancer Therapies 4
- Co-authors
- Maryam B. Lustberg (14 shared papers)Bhuvaneswari Ramaswamy (12 shared papers)Robert Wesolowski (11 shared papers)Charles L. Shapiro (8 shared papers)Ewa Mrózek (7 shared papers)Craig Vargo (11 shared papers)Rachel M. Layman (4 shared papers)Nathan D. Seligson (1 shared paper)
- Journals
- Supportive Care in Cancer (6 papers)Journal of Clinical Oncology (2 papers)Clinical Breast Cancer (2 papers)Annals of Pharmacotherapy (2 papers)Stem Cell Research & Therapy (1 paper)
- Partner nations
- United StatesGermanySwitzerland
In The Last Decade
Michael Berger
25 papers receiving 432 citations
Peers
Comparison fields: 5 of 61
- Oncology 221
- Cancer Research 73
- Dermatology 30
- Pulmonary and Respiratory Medicine 104
- Pharmacology 32
Countries citing papers authored by Michael Berger
This map shows the geographic impact of Michael Berger's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Michael Berger with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Michael Berger more than expected).
Fields of papers citing papers by Michael Berger
This network shows the impact of papers produced by Michael Berger. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Michael Berger. The network helps show where Michael Berger may publish in the future.
Co-authors
The 25 scholars most cited alongside Michael Berger, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
Showing the 20 most-cited of 26 papers — load more, or switch the sort, to bring in the rest.
| # | Work | ||
|---|---|---|---|
| 1 | 2014 | 86 | |
| 2 | 2016 | 54 | |
| 3 | 2020 | 47 | |
| 4 | 2019 | 35 | |
| 5 | 2015 | 34 | |
| 6 | 2013 | 29 | |
| 7 | 2011 | 22 | |
| 8 | 2012 | 20 | |
| 9 | 2014 | 20 | |
| 10 | 2013 | 19 | |
| 11 | 2000 | 14 | |
| 12 | 2014 | 11 | |
| 13 | 2023 | 9 | |
| 14 | 2018 | 6 | |
| 15 | 2011 | 5 | |
| 16 | Spider Telangiectases and Palmar Erythema as Harbingers of Structural Liver Changes in Three Breast Cancer Patients on Ado-trastuzumab Emtansine. | 2019 | 4 |
| 17 | 2019 | 4 | |
| 18 | 2021 | 3 | |
| 19 | 2016 | 3 | |
| 20 | 2020 | 3 |
About Michael Berger
Michael Berger is a scholar working on Oncology, Pulmonary and Respiratory Medicine, Surgery, Pharmacology and Radiology, Nuclear Medicine and Imaging, having authored 26 papers that have together received 436 indexed citations. Recurring topics across this work include Advanced Breast Cancer Therapies (4 papers), HER2/EGFR in Cancer Research (4 papers), Nausea and vomiting management (3 papers), Drug-Induced Adverse Reactions (3 papers), Cancer Cells and Metastasis (3 papers), Monoclonal and Polyclonal Antibodies Research (2 papers), Sympathectomy and Hyperhidrosis Treatments (1 paper) and Lung Cancer Research Studies (1 paper). The work is most often cited by research in Oncology (221 citations), Cancer Research (73 citations), Dermatology (30 citations), Pulmonary and Respiratory Medicine (104 citations) and Pharmacology (32 citations). Michael Berger has collaborated with scholars based in United States, Germany and Switzerland. Frequent co-authors include Maryam B. Lustberg, Bhuvaneswari Ramaswamy, Robert Wesolowski, Charles L. Shapiro, Ewa Mrózek, Craig Vargo, Rachel M. Layman, Nathan D. Seligson, R. Donald Harvey and Gary Phillips. Their work appears in journals such as Supportive Care in Cancer, Journal of Clinical Oncology, Clinical Breast Cancer, Annals of Pharmacotherapy and Stem Cell Research & Therapy.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.